The Zero Childhood Cancer program uses genomics, computational biology and cancer models to better understand the holistic effect of mutations that lead to cancer. Understanding the biological pathways is critical to developing more specific and less harmful treatments. Insight into why certain treatments fail promises better treatment outcomes.

This Love Your Sister grant supports the Liquid Biopsy Program in its efforts to provide a low risk, convenient and far less invasive method of detecting tumours from children and young adults with cancer. This technology also provides the opportunity to assess the growth of cancers at far more regular intervals giving invaluable insight into how tumours progress in real-time. In particular this grant addresses a current gap, by funding a bioinformatics expert for the Functional Genomics & Liquid Biopsy component of the program.